New Landmark Study at UM School of Medicine Finds Aspirin Use Reduces Risk of Death in Hospitalized COVID-19 Patients
- Monday, October 26, 2020, 7:13
- PR Newswire
- Add a comment
BALTIMORE, Oct. 26, 2020 /PRNewswire/ — Hospitalized COVID-19 patients who were taking a daily low-dose aspirin to protect against cardiovascular disease had a significantly lower risk of complications and death compared to those who were not taking aspirin, according to a new study led…